References
- Bakke O. M., Wardell W. M., Lasagna L. Drug discontinuation in the United Kingdom and the United States, 1964 to 1983: issues of safety. Clinical and Pharmacol. Therapeutics 1984; 35: 559–567
- Baynes J. W., Watkins N. G., Fisher C. I., Hull C. J., Patrick J. S., Amhed M. U., Dunn J. A., Thorpe S. R. The Amadori product on protein: structure and reaction. Maillard Reaction in Aging, Diabetes and Nutrition, J. W. Baynes, V. M. Monnier. Alan R. Liss, New York 1989; 43–67
- Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New England Journal of Medicine 1988; 318: 1315–1321
- Dickinson R. G., King A. B. Studies on the reactivity of acyl glucuronides -II: isomerization of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. Biochemical Pharmcology 1991; 42: 2301–2306
- Faed E. M. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metabolism Reviews 1984; 15: 1213–1249
- Hart D., Ward M., Lifschitz M. D. Suprofen-related nephrotoxicity—a distinct clinical syndrome. Annals of International Medicine 1987; 106: 235–238
- Hasegawa J., Smith P. C., Benet L. Z. Apparent intramolecular acyl migration of zomepirac glucuronide. Drug Metabolism and Disposition 1982; 10: 469–473
- Hyneck M. L., Munafo A., Benet L. Z. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide. Drug Metabolism and Disposition 1988; 16: 322–324
- Jentroft N., Dearborn D. G. Labeling of proteins by reductive methylation using sodium cyanoborohydride. Journal of Biological Chemistry 1979; 254: 4359–4365
- Mori Y., Kuroda N., Sakai Y., Yokay F., Toyoshi K., Baba S. Species differences in the metabolism of suprofen in laboratory animals and man. Drug Metabolism and Dispositions 1985; 13: 239–245
- Shetty H. U., Nelson W. L. Attemps to use cyanide ion to trap intermediates in the microsomal N-dealkylation of propranolol: formation of α-aminonitriles as artifacts when using ether for extraction. Journal of Pharmaceutical Science 1985; 74: 968–971
- Smith P. C., Benet L. Z., Mcdonagh A. F. Covalent binding or zomepirac glucuronide proteins: evidence to a schiff base mechanism. Drug Metabolism and Disposition 1990; 18: 639–644
- Smith P. C., Mcdonagh A. F., Benet L. Z. Irreversible binding of zomepirac to plasma proteinsin vitro and in vivo. Journal of Clinical Investigation 1986; 77: 934–939
- Spahn H., Nathke I., Mori K., Zia-Amirhosseini P., Benet L. Z. Preliminary characterization of proteins to which benoxaprofen glucuronide binds irreversibly. Pharmaceutical Research 1990; 7: S257
- Spahn-Langguth H., Benet L. Z. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism?. Drug Metabolism Reviews 1992; 24: 5–48
- Stogniew M., Fenselau C. Electrophilic reactions of acyl-linked glucuronides: formation of clofibrate mercapturate in humans. Drug Metabolism and Disposition 1982; 10: 609–613
- Strom B. L., West S. L., Slim E., Carson J. L. The epidemiology of the acute flank pain syndrome from suprofen. Clinical Pharmacology and Therapeutics 1989; 46: 693–699
- Todd P. A., Heel R. C. Suprofen: a review of its pharmacodynamic and pharmacokinetic properties, and analgesic efficacy. Drugs 1985; 30: 514–538
- Van Breemen R. B., Fenselau C. C. Reactions of 1-O-acyl glucuronides with 4-(p-nitrobenzyl)pyridine. Drug Metabolism and Disposition 1986; 14: 197–201
- Wells D. S., Janssen F. W., Ruelius H. W. Interactions between oxaprozin glucuronide and human serum albumin. Xenobiotica 1987; 17: 1437–1449
- Wu W. N., Ng K. T., Masucci J. Metabolism of suprofen in man—acyl migration of glucuronides. Pharmaceutical Research 1990; 7: 216
- Ziegler R., Ho B., Castagnoli N. Trapping of metabolically generated electrophilic species with cyanide ion: metabolism of methapyrilene. Journal of Medical Chemistry 1981; 24: 1133–1138